Structure-Activity Relationships of the Antimicrobial Peptide Natural Product Apidaecin.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
14 09 2023
Historique:
medline: 15 9 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: ppublish

Résumé

With the growing crisis of antimicrobial resistance, it is critical to continue to seek out new sources of novel antibiotics. This need has led to renewed interest in natural product antimicrobials, specifically antimicrobial peptides. Nonlytic antimicrobial peptides are highly promising due to their unique mechanisms of action. One such peptide is apidaecin (Api), which inhibits translation termination through stabilization of the quaternary complex of the ribosome-apidaecin-tRNA-release factor. Synthetic derivatives of apidaecin have been developed, but structure-guided modifications have yet to be considered. In this work, we have focused on modifying key residues in the Api sequence that are responsible for the interactions that stabilize the quaternary complex. We present one of the first examples of a highly modified Api peptide that maintains its antimicrobial activity and interaction with the translation complex. These findings establish a starting point for further structure-guided optimization of Api peptides.

Identifiants

pubmed: 37603874
doi: 10.1021/acs.jmedchem.3c00406
doi:

Substances chimiques

apidaecin 123997-21-7
Antimicrobial Peptides 0
Antimicrobial Cationic Peptides 0
Biological Products 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

11831-11842

Subventions

Organisme : NIAID NIH HHS
ID : R56 AI162961
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI162961
Pays : United States

Auteurs

Kornelia J Skowron (KJ)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Chetana Baliga (C)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Tatum Johnson (T)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Kyle M Kremiller (KM)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Alexandra Castroverde (A)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Trevor T Dean (TT)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

A'Lester C Allen (AC)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Ana M Lopez-Hernandez (AM)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Elena V Aleksandrova (EV)

Department of Biological Sciences, College of Liberal Arts and Sciences, University of Illinois Chicago, Chicago, Illinois 60607, United States.

Dorota Klepacki (D)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Alexander S Mankin (AS)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.
Center for Biomolecular Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Yury S Polikanov (YS)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.
Department of Biological Sciences, College of Liberal Arts and Sciences, University of Illinois Chicago, Chicago, Illinois 60607, United States.
Center for Biomolecular Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Terry W Moore (TW)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.
University of Illinois Cancer Center, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Articles similaires

Animals Drug Resistance, Multiple, Bacterial Mice Microbial Sensitivity Tests Female
Bacteriocins Humans Anti-Bacterial Agents Bacteria Bacterial Infections

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines
Methicillin-Resistant Staphylococcus aureus Aegle Microbial Sensitivity Tests Molecular Dynamics Simulation Antimicrobial Peptides

Classifications MeSH